Emil D. Kakkis
2012
In 2012, Emil D. Kakkis earned a total compensation of $401.4K as President and Chief Executive Officer at Ultragenyx Pharmaceutical.
Compensation breakdown
| Non-Equity Incentive Plan | $92,125 |
|---|---|
| Salary | $300,172 |
| Other | $9,056 |
| Total | $401,353 |
Kakkis received $300.2K in salary, accounting for 75% of the total pay in 2012.
Kakkis also received $92.1K in non-equity incentive plan and $9.1K in other compensation.
Rankings
In 2012, Emil D. Kakkis' compensation ranked 9,388th out of 11,487 executives tracked by ExecPay. In other words, Kakkis earned more than 18.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,388 out of 11,487 | 18th |
Division Manufacturing | 3,467 out of 4,253 | 19th |
Major group Chemicals And Allied Products | 952 out of 1,198 | 21st |
Industry group Drugs | 713 out of 920 | 23rd |
Industry Pharmaceutical Preparations | 552 out of 700 | 21st |
Source: SEC filing on May 23, 2014.
Kakkis' colleagues
We found two more compensation records of executives who worked with Emil D. Kakkis at Ultragenyx Pharmaceutical in 2012.